Product Description: Simmitecan hydrochloride, a 9-substituted lipophilic Camptothecin (HY-16560) derivative, is a potent topoisomerase I inhibitor. Simmitecan hydrochloride is an anticancer agent[1][2].
Applications: Cancer-programmed cell death
Formula: C34H39ClN4O6
References: [1]Rini B, et al. A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma. Ann Oncol. 2014 Sep;25(9):1794-1799. /[2]Hu ZY, et al. Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals. Acta Pharmacol Sin. 2013 Nov;34(11):1437-48.
CAS Number: 1247847-78-4
Molecular Weight: 635.15
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Cytochrome P450;Topoisomerase